Cue Health Provides Enhanced Care & Protection for Immunocompromised Populations & Clinical Care Teams at Fresenius Kidney Care

SAN DIEGO, Aug. 24, 2022 /PRNewswire/ — Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced a new collaboration with Fresenius Kidney Care to provide the most accurate* COVID-19 self-test to certain patients and clinical care teams. People who are…

Click here to view original post